欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	LT/H/0143/001
药品名称	Cirpofloxacin VIOSER
活性成分	ciprofloxacin 2.0 mg/ml
剂型	Solution for infusion
上市许可持有人	Norameda UAB Gyneju G. 16 Vilniaus M. Sav. Vilnius Vilnius County 01109 Lithuania
参考成员国 - 产品名称	Lithuania (LT) Ciprofloxacin VIOSER 2 mg/ml infuzinis tirpalas
互认成员国 - 产品名称	Romania (RO) Ciprofloxacin VIOSER 2 mg/ml soluţie perfuzabilă Greece (GR) Poland (PL) Cirpofloxacin VIOSER Latvia (LV) Ciprofloxacin Vioser 2 mg/ml šķīdums infūzijām Estonia (EE) CIPROFLOXACIN NORAMEDA Cyprus (CY) Ciprofloxacin VIOSER 2mg/ml διάλυμα για έγχυση
许可日期	2021/04/22
最近更新日期	2024/03/18
药物ATC编码	J01MA02 ciprofloxacin
申请类型	TypeLevel1：Known Active Substance TypeLevel2：Initial Application TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final Product Information \| LT-H-0143-001-DC_Ciprofloxacin_D210_SmPC_2021 04 22Date of last change:2021/08/31 Final SPC \| LT-H-0143-001-DC_Ciprofloxacin_D210_PL_2021 04 22_markedDate of last change:2021/08/31 Final SPC \| LT-H-0143-001-DC_Ciprofloxacin_D210_SmPC_2021 04 22_markedDate of last change:2021/08/31 Final Product Information \| LT-H-0143-001-DC_Ciprofloxacin_D210_LB_impack_2021 04 22Date of last change:2021/08/31 Final Product Information \| LT-H-0143-001-DC_Ciprofloxacin_D210_LB_impack_multilingual_2021 04 22Date of last change:2021/08/31 Final Product Information \| LT-H-0143-001-DC_Ciprofloxacin_D210_LB_outer_2021 04 22Date of last change:2021/08/31 Final Product Information \| LT-H-0143-001-DC_Ciprofloxacin_D210_LB_outer_multilingual_2021 04 22Date of last change:2021/08/31 Final Product Information \| LT-H-0143-001-DC_Ciprofloxacin_D210_PL_2021 04 22Date of last change:2021/08/31
市场状态	Positive